88 related articles for article (PubMed ID: 18959820)
1. FoxO3a mediates transforming growth factor-beta1-induced apoptosis in FaO rat hepatoma cells.
Kim BC
BMB Rep; 2008 Oct; 41(10):728-32. PubMed ID: 18959820
[TBL] [Abstract][Full Text] [Related]
2. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
3. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling.
Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C
Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462
[TBL] [Abstract][Full Text] [Related]
4. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines.
Wang CL; Wan YL; Liu YC; Huang ZQ
Chin Med Sci J; 2006 Mar; 21(1):33-5. PubMed ID: 16615282
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate 2 and FoxO3a signalling are involved in E-cadherin expression and transforming growth factor-β1-induced repression in kidney epithelial cells.
Carew RM; Browne MB; Hickey FB; Brazil DP
FEBS J; 2011 Sep; 278(18):3370-80. PubMed ID: 21777391
[TBL] [Abstract][Full Text] [Related]
7. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF
World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190
[TBL] [Abstract][Full Text] [Related]
9. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease.
Kato M; Yuan H; Xu ZG; Lanting L; Li SL; Wang M; Hu MC; Reddy MA; Natarajan R
J Am Soc Nephrol; 2006 Dec; 17(12):3325-35. PubMed ID: 17082237
[TBL] [Abstract][Full Text] [Related]
10. ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line.
Choi KS; Lim IK; Brady JN; Kim SJ
Hepatology; 1998 Feb; 27(2):415-21. PubMed ID: 9462639
[TBL] [Abstract][Full Text] [Related]
11. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
[TBL] [Abstract][Full Text] [Related]
12. Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1.
Vivar R; Humeres C; Anfossi R; Bolivar S; Catalán M; Hill J; Lavandero S; Diaz-Araya G
Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118695. PubMed ID: 32169420
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of human hepatoma cell lines induced by transforming growth factor beta 1 (TGF-beta1) correlates with p53 and Smad4 activation.
Wang CL; Wan YL; Liu YC; Huang ZQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):176-8. PubMed ID: 16617361
[TBL] [Abstract][Full Text] [Related]
14. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
15. Transcription Factor Forkhead Box O1 Mediates Transforming Growth Factor-β1-Induced Apoptosis in Hepatocytes.
Chen Y; Pan Q; Liao W; Ai W; Yang S; Guo S
Am J Pathol; 2023 Sep; 193(9):1143-1155. PubMed ID: 37263346
[TBL] [Abstract][Full Text] [Related]
16. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
17. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
18. Juglanthraquinone C Induces Intracellular ROS Increase and Apoptosis by Activating the Akt/Foxo Signal Pathway in HCC Cells.
Hou YQ; Yao Y; Bao YL; Song ZB; Yang C; Gao XL; Zhang WJ; Sun LG; Yu CL; Huang YX; Wang GN; Li YX
Oxid Med Cell Longev; 2016; 2016():4941623. PubMed ID: 26682007
[TBL] [Abstract][Full Text] [Related]
19. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
He L; Yang X; Cao X; Liu F; Quan M; Cao J
Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
